Though this combination or single agent significantly caused the apoptosis of both KRAS mutant cancer cells and wild-type cells, it is observed that the two inhibitor’s combination obviously enhanced the ability of apoptosis induction in lung cancer cells harboring KRAS mutation. Here, KRAS is linked to lung carcinoma.